Hi-tech ‘Trojan horse’ can kill cancer cells: researchers
Australian researchers are set to begin human trials of a tiny nano-cell that acts as a “Trojan horse” against cancer cells, a breakthrough they say may curb the need for debilitating chemotherapy.
The technology could eventually allow cancer sufferers to receive treatment as outpatients, rather than being hospitalised for lengthy bouts of chemotherapy, according to the researchers.
Himanshu Brahmbhatt from Sydney-based biotechnology company EnGeneIC said the research — outlined in the journal Nature Biotechnology — had the potential to reduce the side-effects of cancer treatment and make it cheaper.
Brahmbhatt said the technology allowed medics to target cancer cells without damaging healthy tissue, a major problem with existing chemotherapy treatments.
|
 |
